Trial intelligence / Profile preview

Evaluation of hepatic and renal function algorithms for fosravuconazole in real-world clinical practice

jRCT1070250090Active, not recruiting

Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of fosravuconazole in onychomycosis, sponsored by none. Primary endpoints: AST, ALT and 3 more. Started Nov 2025; status: active, not recruiting.

02

Drugs

fosravuconazole
03

Conditions

onychomycosis

Beyond the preview

Go deeper on jRCT1070250090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1070250090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call